AGITATED SOLUTIONS, INC.
About AGITATED SOLUTIONS, INC.
AGITATED SOLUTIONS, INC. is a clinical-stage medical technology company developing tools to improve ultrasound imaging and diagnosis across multiple clinical applications. Its first product, the Orbis Microbubble Generator, received Canadian medical device licensing in 2024 and is in clinical use. The company is preparing for a U.S. Phase 3 trial in cardiology for its investigational ultrasound imaging agent ASI-02 and developing proprietary software to aid in cardiac shunt assessment. Headquartered in Saint Paul, MN, it was incorporated on June 21, 2023.
- 🔗 Agitated Solutions - 2026 Company Profile, Team & Funding - Tracxn
- 🔗 Agitated Solutions Announces W. L. Gore & Associates Joins Series B Investment Syndicate — Agitated Solutions
- 🔗 Agitated Solutions, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
- 🔗 Agitated Solutions - 2026 Funding Rounds & List of Investors - Tracxn
- 🔗 Agitated Solutions - Products, Competitors, Financials, Employees, Headquarters Locations
Key highlights
- Raised $6.385M in private placement with proceeds supporting Phase III trial and software development.
- W. L. Gore & Associates joined Series B syndicate to advance ultrasound imaging agent ASI-02.
- Orbis Microbubble Generator received Canadian licensing in 2024 and entered clinical use.
- Total funding across rounds reaches $9.78M with institutional investors including Engage Venture Partners.
- Focus on improving diagnostic accuracy in cardiology through microbubble technology and AI-assisted software.
Ask StreetZero about AGITATED SOLUTIONS, INC.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account